A Comparison of the Immunogenicity and Safety of Quinvaxem in Mono-dose Vials and Uniject

Clinical trial NCT01917357 · COMPLETED

Trial details

NCT number: NCT01917357
Sponsor: Crucell Holland BV
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diphtheria Pertussis Tetanus Hepatitis B Haemophilus Infections

Start date: 2013-09-01
Primary completion: 2014-04-01
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.